Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 629

1.

[Extranodal manifestation of classical Hodgkin lymphoma in the head and neck region].

Völker HU, Becker E, Müller-Hermelink HK, Scheich M.

HNO. 2020 Jan;68(1):32-39. doi: 10.1007/s00106-019-00781-4. German.

PMID:
31712877
2.

[Ten years of telepathology for a mission hospital in Tanzania].

Völker HU, Müller-Hermelink HK, Stüfe A, Strehl A, Pötzl L, Stauch G.

Pathologe. 2019 Sep;40(5):519-526. doi: 10.1007/s00292-019-0641-0. German.

PMID:
31338564
3.

A modular transcriptome map of mature B cell lymphomas.

Loeffler-Wirth H, Kreuz M, Hopp L, Arakelyan A, Haake A, Cogliatti SB, Feller AC, Hansmann ML, Lenze D, Möller P, Müller-Hermelink HK, Fortenbacher E, Willscher E, Ott G, Rosenwald A, Pott C, Schwaenen C, Trautmann H, Wessendorf S, Stein H, Szczepanowski M, Trümper L, Hummel M, Klapper W, Siebert R, Loeffler M, Binder H; German Cancer Aid consortium Molecular Mechanisms for Malignant Lymphoma.

Genome Med. 2019 Apr 30;11(1):27. doi: 10.1186/s13073-019-0637-7.

4.

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD.

Haematologica. 2016 Oct;101(10):1244-1250. Epub 2016 Jun 27.

5.

Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.

Perry AM, Perner Y, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD.

Br J Haematol. 2016 Mar;172(5):716-23. doi: 10.1111/bjh.13885. Epub 2015 Dec 21.

PMID:
26898194
6.

Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.

Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD.

Br J Haematol. 2016 Mar;172(5):699-708. doi: 10.1111/bjh.13876. Epub 2015 Dec 18.

PMID:
26684877
7.

Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project.

Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD.

Ann Hematol. 2016 Jan;95(2):245-51. doi: 10.1007/s00277-015-2543-4. Epub 2015 Nov 5.

PMID:
26537613
8.

Non-Hodgkin lymphoma in Romania: a single-centre experience.

Fetica B, Achimas-Cadariu P, Pop B, Dima D, Petrov L, Perry AM, Nathwani BN, Müller-Hermelink HK, Diebold J, MacLennan KA, Fulop A, Blaga ML, Coza D, Nicula FA, Irimie A, Weisenburger DD.

Hematol Oncol. 2017 Jun;35(2):198-205. doi: 10.1002/hon.2266. Epub 2015 Oct 20.

PMID:
26482423
9.

Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project.

Dotlic S, Perry AM, Petrusevska G, Fetica B, Diebold J, MacLennan KA, Müller-Hermelink HK, Nathwani BN, Boilesen E, Bast M, Armitage JO, Weisenburger DD.

Br J Haematol. 2015 Nov;171(3):366-72. doi: 10.1111/bjh.13586. Epub 2015 Jul 27.

PMID:
26213902
10.

Fatal Human Meningoencephalitis due to Halicephalobus Nematodes, Germany.

Monoranu CM, Müllges W, Keppler M, Brehm K, Ondrejka SL, Muntau B, Tannich E, Müller-Hermelink HK, Tappe D.

Open Forum Infect Dis. 2015 May 22;2(2):ofv061. doi: 10.1093/ofid/ofv061. eCollection 2015 Apr.

11.

Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification.

Boudjerra N, Perry AM, Audouin J, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD.

Leuk Lymphoma. 2015 Apr;56(4):965-70. doi: 10.3109/10428194.2014.939967. Epub 2014 Aug 20.

PMID:
25012941
12.

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c.

Huang B, Belharazem D, Li L, Kneitz S, Schnabel PA, Rieker RJ, Körner D, Nix W, Schalke B, Müller-Hermelink HK, Ott G, Rosenwald A, Ströbel P, Marx A.

Front Oncol. 2013 Dec 31;3:316. doi: 10.3389/fonc.2013.00316. eCollection 2013.

13.

Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.

Chuang WY, Ströbel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, Müller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A.

J Autoimmun. 2014 Aug;52:122-9. doi: 10.1016/j.jaut.2013.12.006. Epub 2013 Dec 24.

PMID:
24373506
14.

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.

Laurini JA, Perry AM, Boilesen E, Diebold J, Maclennan KA, Müller-Hermelink HK, Nathwani BN, Armitage JO, Weisenburger DD.

Blood. 2012 Dec 6;120(24):4795-801. doi: 10.1182/blood-2012-07-440073. Epub 2012 Oct 18.

PMID:
23086753
15.

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM.

Nature. 2012 Oct 4;490(7418):116-20. doi: 10.1038/nature11378. Epub 2012 Aug 12.

16.

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists.

Cabrera ME, Martinez V, Nathwani BN, Muller-Hermelink HK, Diebold J, Maclennan KA, Armitage J, Weisenburger DD.

Leuk Lymphoma. 2012 Jul;53(7):1311-7. doi: 10.3109/10428194.2012.654471. Epub 2012 Mar 13. Review.

PMID:
22263570
17.

State-of-the-art classification and multimodality treatment of malignant thymoma.

Koppitz H, Rockstroh JK, Schüller H, Standop J, Skowasch D, Müller-Hermelink HK, Schmidt-Wolf IG.

Cancer Treat Rev. 2012 Aug;38(5):540-8. doi: 10.1016/j.ctrv.2011.11.010. Epub 2012 Jan 13. Review.

PMID:
22244677
18.

[Reflections of a Virchow medal laureate].

Müller-Hermelink HK.

Pathologe. 2011 Nov;32 Suppl 2:167-73. doi: 10.1007/s00292-011-1528-x. German. No abstract available.

PMID:
22033680
19.

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system.

Perry AM, Molina-Kirsch H, Nathwani BN, Diebold J, Maclennan KA, Müller-Hermelink HK, Armitage JO, Weisenburger DD.

Leuk Lymphoma. 2011 Sep;52(9):1681-8. doi: 10.3109/10428194.2011.584254. Epub 2011 Jun 3.

PMID:
21635203
20.

Oncogenically active MYD88 mutations in human lymphoma.

Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM.

Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.

21.

Cooperative epigenetic modulation by cancer amplicon genes.

Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Weisenburger DD, Chan WC, Gascoyne RD, Levens D, Staudt LM.

Cancer Cell. 2010 Dec 14;18(6):590-605. doi: 10.1016/j.ccr.2010.11.013.

22.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sökler M, Ho A, Rank A, Ganser A, Trümper L, Bokemeyer C, Kirchner H, Schubert J, Král Z, Fuchs M, Müller-Hermelink HK, Müller RP, Diehl V.

N Engl J Med. 2010 Aug 12;363(7):640-52. doi: 10.1056/NEJMoa1000067.

23.

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

Ott G, Ziepert M, Klapper W, Horn H, Szczepanowski M, Bernd HW, Thorns C, Feller AC, Lenze D, Hummel M, Stein H, Müller-Hermelink HK, Frank M, Hansmann ML, Barth TF, Möller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trümper L, Loeffler M, Rosenwald A.

Blood. 2010 Dec 2;116(23):4916-25. doi: 10.1182/blood-2010-03-276766. Epub 2010 Aug 24.

PMID:
20736456
24.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J, Ho A, Dörken B, Rank A, Grosu AL, Wiegel T, Karstens JH, Greil R, Willich N, Schmidberger H, Döhner H, Borchmann P, Müller-Hermelink HK, Müller RP, Engert A.

J Clin Oncol. 2010 Sep 20;28(27):4199-206. doi: 10.1200/JCO.2010.29.8018. Epub 2010 Aug 16.

PMID:
20713848
25.

Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations.

Geissinger E, Sadler P, Roth S, Grieb T, Puppe B, Müller N, Reimer P, Vetter-Kauczok CS, Wenzel J, Bonzheim I, Rüdiger T, Müller-Hermelink HK, Rosenwald A.

Haematologica. 2010 Oct;95(10):1697-704. doi: 10.3324/haematol.2009.021428. Epub 2010 May 29.

26.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD.

N Engl J Med. 2010 Mar 11;362(10):875-85. doi: 10.1056/NEJMoa0905680.

27.

A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.

Gattenlöhner S, Jörissen H, Huhn M, Vincent A, Beeson D, Tzartos S, Mamalaki A, Etschmann B, Muller-Hermelink HK, Koscielniak E, Barth S, Marx A.

J Biomed Biotechnol. 2010;2010:187621. doi: 10.1155/2010/187621. Epub 2010 Feb 24.

28.

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.

Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, Fornari A, Martinoglio B, Medico E, Zamò A, Facchetti F, Ponzoni M, Geissinger E, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G.

J Clin Oncol. 2010 Mar 20;28(9):1583-90. doi: 10.1200/JCO.2008.20.9759. Epub 2010 Feb 16.

PMID:
20159827
29.

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM.

Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638.

30.

Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.

Eichenauer DA, Bredenfeld H, Haverkamp H, Müller H, Franklin J, Fuchs M, Borchmann P, Müller-Hermelink HK, Eich HT, Müller RP, Diehl V, Engert A.

J Clin Oncol. 2009 Dec 20;27(36):6079-85. doi: 10.1200/JCO.2008.20.2655. Epub 2009 Nov 9.

PMID:
19901121
31.

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.

Bernd HW, Ziepert M, Thorns C, Klapper W, Wacker HH, Hummel M, Stein H, Hansmann ML, Ott G, Rosenwald A, Müller-Hermelink HK, Barth TF, Möller P, Cogliatti SB, Pfreundschuh M, Schmitz N, Trümper L, Höller S, Löffler M, Feller AC; German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Haematologica. 2009 Nov;94(11):1569-80. doi: 10.3324/haematol.2009.008862.

32.

Laryngeal inflammatory myofibroblastic tumors: Different clinical appearance and histomorphologic presentation of one entity.

Völker HU, Scheich M, Zettl A, Hagen R, Müller-Hermelink HK, Gattenlöhner S.

Head Neck. 2010 Nov;32(11):1573-8. doi: 10.1002/hed.21232.

PMID:
19787794
33.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Engert A, Diehl V, Franklin J, Lohri A, Dörken B, Ludwig WD, Koch P, Hänel M, Pfreundschuh M, Wilhelm M, Trümper L, Aulitzky WE, Bentz M, Rummel M, Sezer O, Müller-Hermelink HK, Hasenclever D, Löffler M.

J Clin Oncol. 2009 Sep 20;27(27):4548-54. doi: 10.1200/JCO.2008.19.8820. Epub 2009 Aug 24.

PMID:
19704068
34.

The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.

Chuang WY, Ströbel P, Belharazem D, Rieckmann P, Toyka KV, Nix W, Schalke B, Gold R, Kiefer R, Klinker E, Opitz A, Inoue M, Kuo TT, Müller-Hermelink HK, Marx A.

Genes Immun. 2009 Dec;10(8):667-72. doi: 10.1038/gene.2009.64. Epub 2009 Aug 20.

PMID:
19693092
35.

Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.

Kaune KM, Baumgart M, Bertsch HP, Mitteldorf C, Müller-Hermelink HK, Haase D, Ghadimi BM, Schön MP, Neumann C.

Am J Dermatopathol. 2009 Oct;31(7):695-701. doi: 10.1097/DAD.0b013e3181a5e13d.

PMID:
19684511
36.

Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.

Stöcklein H, Hutter G, Kalla J, Hartmann E, Zimmermann Y, Katzenberger T, Adam P, Leich E, Höller S, Müller-Hermelink HK, Rosenwald A, Ott G, Dreyling M.

J Hematop. 2008 Sep;1(2):85-95. doi: 10.1007/s12308-008-0008-6. Epub 2008 Jul 5.

37.

Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Bonzheim I, Geissinger E, Chuang WY, Roth S, Ströbel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Müller-Hermelink HK, Rüdiger T.

J Hematop. 2008 Jul;1(1):11-21. doi: 10.1007/s12308-008-0003-y. Epub 2008 Apr 24.

38.

Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants.

Morbach H, Dick A, Beck C, Stenzel M, Müller-Hermelink HK, Raab P, Girschick HJ.

Rheumatol Int. 2010 Mar;30(5):617-21. doi: 10.1007/s00296-009-1029-x. Epub 2009 Jul 5.

PMID:
19579029
39.

Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses.

Völker HU, Scheich M, Berndt A, Haubitz I, Metzger A, Müller-Hermelink HK, Kämmerer U, Schmidt M.

Diagn Pathol. 2009 Jun 19;4:18. doi: 10.1186/1746-1596-4-18.

40.

CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies.

Geissinger E, Bonzheim I, Roth S, Rosenwald A, Müller-Hermelink HK, Rüdiger T.

Leuk Lymphoma. 2009 Jun;50(6):1010-6. doi: 10.1080/10428190902926981.

PMID:
19479612
41.

Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.

Fenske W, Völker HU, Adam P, Hahner S, Johanssen S, Wortmann S, Schmidt M, Morcos M, Müller-Hermelink HK, Allolio B, Fassnacht M.

Endocr Relat Cancer. 2009 Sep;16(3):919-28. doi: 10.1677/ERC-08-0211. Epub 2009 May 23.

PMID:
19465749
42.

Leiomyosarcoma of the larynx as a local relapse of squamous cell carcinoma--report of an unusual case.

Völker HU, Zettl A, Haralambieva E, Blume B, Hagen R, Müller-Hermelink HK, Scheich M.

Head Neck. 2010 May;32(5):679-83. doi: 10.1002/hed.21127.

PMID:
19441090
43.

Lack of KRAS and BRAF mutation in renal cell carcinoma.

Gattenlöhner S, Etschmann B, Riedmiller H, Müller-Hermelink HK.

Eur Urol. 2009 Jun;55(6):1490-1. doi: 10.1016/j.eururo.2009.02.024. Epub 2009 Feb 28. No abstract available.

PMID:
19282104
44.

Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx--value of conventional evaluation and additional immunohistochemical staining of D2-40.

Völker HU, Scheich M, Nowack I, Metzger A, Haubitz I, Puppe B, Hagen R, Müller-Hermelink HK, Völter C.

World J Surg Oncol. 2009 Mar 4;7:25. doi: 10.1186/1477-7819-7-25.

45.

Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Gattenlöhner S, Stühmer T, Leich E, Reinhard M, Etschmann B, Völker HU, Rosenwald A, Serfling E, Bargou RC, Ertl G, Einsele H, Müller-Hermelink HK.

Am J Pathol. 2009 Apr;174(4):1160-71. doi: 10.2353/ajpath.2009.080647. Epub 2009 Feb 26.

46.

K-ras mutations and cetuximab in colorectal cancer.

Gattenlohner S, Germer C, Muller-Hermelink HK.

N Engl J Med. 2009 Feb 19;360(8):835; author reply 835-6. No abstract available.

PMID:
19238678
47.

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score.

Höller S, Horn H, Lohr A, Mäder U, Katzenberger T, Kalla J, Bernd HW, Went P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

J Hematop. 2009 Sep 2;2(4):187-94. doi: 10.1007/s12308-009-0044-x.

48.

Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy.

Gattenlöhner S, Etschmann B, Kunzmann V, Thalheimer A, Hack M, Kleber G, Einsele H, Germer C, Müller-Hermelink HK.

J Oncol. 2009;2009:831626. doi: 10.1155/2009/831626. Epub 2010 Mar 10.

49.

[Middle ear adenoma/middle ear carcinoid--an unproblematic tumor?].

Strehl MA, Scheich M, Ott I, Müller-Hermelink HK, Hagen R, Völker HU.

Laryngorhinootologie. 2009 Mar;88(3):186-90. doi: 10.1055/s-0028-1102933. Epub 2008 Dec 8. German.

PMID:
19065497
50.

Concomitant Herpes simplex and Epstein-Barr virus lymphadenitis with simultaneous lymph node metastases of an occult squamous cell carcinoma in a patient with chronic lymphocytic leukemia.

Gattenlohner S, Etschmann B, Lippert BM, Rumpelt HJ, Einsele H, Müller-Hermelink HK.

Leuk Lymphoma. 2008 Dec;49(12):2390-2. doi: 10.1080/10428190802491680. No abstract available.

PMID:
19052994

Supplemental Content

Loading ...
Support Center